{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-21",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "0363-0157",
      "generic_name": "Aspirin",
      "labeler_name": "Walgreen Company",
      "brand_name": "Aspirin Regular Strength",
      "brand_name_suffix": "Regular Strength",
      "active_ingredients": [
        {
          "name": "ASPIRIN",
          "strength": "325 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "0363-0157-14",
          "description": "500 TABLET, FILM COATED in 1 BOTTLE (0363-0157-14)",
          "marketing_start_date": "19960210",
          "sample": false
        },
        {
          "package_ndc": "0363-0157-98",
          "description": "100 TABLET, FILM COATED in 1 BOTTLE (0363-0157-98)",
          "marketing_start_date": "19960210",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Walgreen Company"
        ],
        "rxcui": [
          "212033"
        ],
        "spl_set_id": [
          "0b27c0fd-7ea8-4588-9169-5ad4e8df77ef"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0311917084381"
        ],
        "nui": [
          "N0000000160",
          "N0000008836",
          "M0001335",
          "N0000175722",
          "N0000175578",
          "N0000008832"
        ],
        "pharm_class_moa": [
          "Cyclooxygenase Inhibitors [MoA]"
        ],
        "pharm_class_pe": [
          "Decreased Prostaglandin Production [PE]",
          "Decreased Platelet Aggregation [PE]"
        ],
        "pharm_class_cs": [
          "Anti-Inflammatory Agents, Non-Steroidal [CS]"
        ],
        "pharm_class_epc": [
          "Nonsteroidal Anti-inflammatory Drug [EPC]",
          "Platelet Aggregation Inhibitor [EPC]"
        ],
        "unii": [
          "R16CO5Y76E"
        ]
      },
      "marketing_category": "OTC MONOGRAPH DRUG",
      "dosage_form": "TABLET, FILM COATED",
      "spl_id": "f0381bfa-fd3f-4242-9baf-0b84dfaa4660",
      "product_type": "HUMAN OTC DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "19960210",
      "product_id": "0363-0157_f0381bfa-fd3f-4242-9baf-0b84dfaa4660",
      "application_number": "M013",
      "brand_name_base": "Aspirin",
      "pharm_class": [
        "Anti-Inflammatory Agents",
        "Non-Steroidal [CS]",
        "Cyclooxygenase Inhibitors [MoA]",
        "Decreased Platelet Aggregation [PE]",
        "Decreased Prostaglandin Production [PE]",
        "Nonsteroidal Anti-inflammatory Drug [EPC]",
        "Platelet Aggregation Inhibitor [EPC]"
      ]
    }
  ]
}